| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11882-018-0778-6 |
| P698 | PubMed publication ID | 29574562 |
| P2093 | author name string | David Ostrov | |
| Daniel Yerly | |||
| S Shahzad Mustafa | |||
| P2860 | cites work | Cyclosporine in Stevens Johnson syndrome and toxic epidermal necrolysis and retrospective comparison with systemic corticosteroid | Q87306495 |
| Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis | Q87323549 | ||
| Glutathione synthesis | Q26864265 | ||
| Genetic variations in HLA-B region and hypersensitivity reactions to abacavir | Q28214097 | ||
| Medical genetics: a marker for Stevens-Johnson syndrome | Q28254047 | ||
| Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses | Q28538078 | ||
| A method for estimating the probability of adverse drug reactions | Q29616247 | ||
| A 10-year experience with toxic epidermal necrolysis | Q33332798 | ||
| Hematological abnormalities and the use of granulocyte-colony-stimulating factor in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis | Q33398324 | ||
| Anticonvulsant hypersensitivity syndrome: incidence, prevention and management | Q33804473 | ||
| Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications | Q34016299 | ||
| Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases | Q34023503 | ||
| ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis | Q34109098 | ||
| Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir | Q34117815 | ||
| HLA-B*13:01 and the dapsone hypersensitivity syndrome. | Q34379784 | ||
| Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. | Q34502241 | ||
| A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century | Q34554434 | ||
| Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese | Q34629177 | ||
| HLA-B*5701 screening for hypersensitivity to abacavir | Q34747145 | ||
| A systematic review of the management and outcome of toxic epidermal necrolysis treated in burns centres | Q35135732 | ||
| High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits. | Q35897124 | ||
| Flare-up reactions in severe drug hypersensitivity: infection or ongoing T-cell hyperresponsiveness | Q36188341 | ||
| Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea | Q36189843 | ||
| Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis | Q36318645 | ||
| Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer | Q36590427 | ||
| Successful translation of pharmacogenetics into the clinic: the abacavir example | Q37436365 | ||
| Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore | Q37763744 | ||
| Efficacy of plasmapheresis for the treatment of severe toxic epidermal necrolysis: Is cytokine expression analysis useful in predicting its therapeutic efficacy? | Q37845912 | ||
| The DRESS syndrome: a literature review | Q37876982 | ||
| The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis. | Q37998131 | ||
| Toxic epidermal necrolysis: performance of SCORTEN and the score-based comparison of the efficacy of corticosteroid therapy and intravenous immunoglobulin combined therapy in China | Q38041396 | ||
| Indications and outcomes of amniotic membrane transplantation in the management of acute stevens-johnson syndrome and toxic epidermal necrolysis: a case-control study | Q38058426 | ||
| Epidemiology of severe drug hypersensitivity | Q38231029 | ||
| Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group | Q38594812 | ||
| U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016. | Q38851480 | ||
| Combination analysis in genetic polymorphisms of drug-metabolizing enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese population | Q39065445 | ||
| Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice | Q39291741 | ||
| CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis | Q39743586 | ||
| Effect of Infectious Diseases on the Pathogenesis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis | Q40068693 | ||
| Clinical manifestations and characteristics of patients with acute generalized exanthematous pustulosis in Asia | Q40411784 | ||
| A retrospective analysis of Stevens-Johnson syndrome/toxic epidermal necrolysis treated with corticosteroids | Q40492475 | ||
| Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults | Q40730824 | ||
| Therapeutic management of DRESS: a retrospective study of 38 cases | Q41577758 | ||
| Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome | Q41659973 | ||
| Characterization of Peroxidases Expressed in Human Antigen Presenting Cells and Analysis of the Covalent Binding of Nitroso Sulfamethoxazole to Myeloperoxidase | Q41660279 | ||
| Multiple Drug Hypersensitivity. | Q42135491 | ||
| Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation | Q43286373 | ||
| A case of recalcitrant DRESS syndrome with multiple autoimmune sequelae treated with intravenous immunoglobulins | Q43793959 | ||
| Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity | Q43859481 | ||
| Toxic epidermal necrolysis treated with N-acetylcysteine | Q43893781 | ||
| Cutaneous disease and drug reactions in HIV infection | Q44111761 | ||
| Characterization of human T cells that regulate neutrophilic skin inflammation. | Q44987505 | ||
| Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis | Q44989249 | ||
| Antishear therapy for toxic epidermal necrolysis: an alternative treatment approach | Q46445120 | ||
| HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis. | Q46859144 | ||
| Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel | Q46963627 | ||
| A 6-month prospective survey of cutaneous drug reactions in a hospital setting | Q47370122 | ||
| Successful treatment of toxic epidermal necrolysis using plasmapheresis: A prospective observational study | Q47839764 | ||
| Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches. | Q47856613 | ||
| Beneficial effect of plasma exchange in the treatment of toxic epidermal necrolysis: a series of four cases. | Q48032546 | ||
| Cyclophosphamide in the treatment of toxic epidermal necrolysis. | Q48908919 | ||
| New Evidence Supporting Cyclosporine Efficacy in Epidermal Necrolysis. | Q49895372 | ||
| SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation. | Q50115047 | ||
| Granulocyte colony-stimulating factor in toxic epidermal necrolysis (TEN) and Chelsea & Westminster TEN management protocol [corrected]. | Q50783206 | ||
| Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. | Q51014122 | ||
| Toxic epidermal necrolysis (TEN): the Chelsea and Westminster Hospital wound management algorithm. | Q51083553 | ||
| Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? | Q55982597 | ||
| Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis | Q56503937 | ||
| Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions | Q59112513 | ||
| Poor Benefit/Risk Balance of Intravenous Immunoglobulins in DRESS | Q61479899 | ||
| Etanercept therapy for toxic epidermal necrolysis | Q61945916 | ||
| Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine | Q73348349 | ||
| Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? | Q73564077 | ||
| Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center | Q77291081 | ||
| Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis | Q77647580 | ||
| Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis | Q81795004 | ||
| Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis | Q82066745 | ||
| Successful treatment of toxic epidermal necrolysis/Stevens-Johnson syndrome overlap with human granulocyte colony stimulating factor: a case report | Q82431984 | ||
| Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis | Q83363467 | ||
| NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions | Q84701343 | ||
| Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy | Q85467978 | ||
| The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre | Q85639675 | ||
| Toxic epidermal necrolysis treated with N-acetylcysteine | Q85840753 | ||
| Acute generalized exanthematous pustulosis: a retrospective audit of practice between 1994 and 2011 at a single centre | Q85973886 | ||
| Adjuvant Role of Amniotic Membrane Transplantation in Acute Ocular Stevens-Johnson Syndrome: A Randomized Control Trial | Q86943795 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 26 | |
| P577 | publication date | 2018-03-24 | |
| P1433 | published in | Current Allergy and Asthma Reports | Q2246111 |
| P1476 | title | Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management | |
| P478 | volume | 18 |
| Q58581821 | Stevens-Johnson syndrome | cites work | P2860 |
Search more.